BOI Share Price

Open 89.50 Change Price %
High 89.50 1 Day -0.30 -0.34
Low 88.74 1 Week -1.95 -2.14
Close 89.15 1 Month 7.75 9.52
Volume 4708 1 Year 16.31 22.39
52 Week High 92.91
52 Week Low 66.10
BOI Important Levels
Resistance 2 89.85
Resistance 1 89.56
Pivot 89.13
Support 1 88.74
Support 2 88.45
EPA France Most Active Stocks
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
AVQ 0.47 0.00%
GSZ 17.56 3.97%
GSZ 17.56 3.97%
GSZ 17.56 3.97%
BRS 12.00 0.00%
More..
EPA France Top Gainers Stocks
MLGEO 0.03 50.00%
MLDIG 1.20 33.33%
RX 5.26 30.20%
RX 5.26 30.20%
RX 5.26 30.20%
ALALO 0.10 25.00%
DBG 6.33 21.97%
MLVER 8.00 18.52%
APAM 33.78 15.72%
APAM 33.78 15.72%
More..
EPA France Top Losers Stocks
OXI 0.06 -14.29%
OXI 0.06 -14.29%
MLAAE 4.50 -10.00%
ALDV 0.09 -10.00%
CIB 0.09 -10.00%
CIB 0.09 -10.00%
CIB 0.09 -10.00%
CIB 0.09 -10.00%
MLGES 2.30 -8.00%
ASY 35.05 -5.27%
More..

Boiron (EPA: BOI)

BOI Technical Analysis 4
As on 23rd May 2017 BOI Share Price closed @ 89.15 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 83.74 & Buy for SHORT-TERM with Stoploss of 86.25 we also expect STOCK to react on Following IMPORTANT LEVELS.
BOI Target for May
1st Target up-side 91.3
2nd Target up-side 94.12
3rd Target up-side 96.94
1st Target down-side 83.26
2nd Target down-side 80.44
3rd Target down-side 77.62
BOI Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.boiron.com
BOI Address
BOI
2, avenue de l
Messimy, 69510
France
Phone: 33 4 78 45 61 00
BOI Latest News
Interactive Technical Analysis Chart Boiron ( BOI EPA France )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Boiron
BOI Business Profile
Boiron SA, a pharmaceutical company, together with its subsidiaries, manufactures and sells nonproprietary homeopathic medicines and OTC medication specialties. It offers homeopathic medicines in two family groups, including medicines associated with precise therapeutic indications and dosage in the form of tablets, syrups, creams, and single-dose liquids; and medicines that do not mention a therapeutic indication or dosage in the form of tubes, granular tubes, and cellular doses. The company produces its medicines by using vegetable, animal, and mineral substances. It primarily operates in France, rest of Europe, and North America. Boiron SA was founded in 1932 and is headquartered in Messimy, France.